TITOMIC
26.5.2021 07:00:09 CEST | Business Wire | Press release
Titomic is delighted to announce that Herbert Koeck, a recognised expert in 3D printing solutions, has been appointed by the Board of Directors as Chief Executive Officer, effective 1 July 2021. He succeeds Norbert Schulze, Interim CEO, who will continue to support the Company in a different role.
For the last five years Mr Koeck has been a member of the executive management team of 3D-Systems Corporation, a leading 3D-printing solution supplier. As Executive Vice-President Global-Go-To-Market he was accountable for the sales and global orders of the group which included influencing product development to ensure customer success. Before joining 3D-Systems, Mr Koeck was Managing Director, EMEA at Hewlett Packard and Senior Vice-President for the PC and Printing Solution Group.
Titomic Chairman Dr Andreas Schwer, commented: “Herbert is a proven leader with deep additive manufacturing experience, hard core marketing skills, business vision and ability to bring people together. During this exciting time of transformation, Herbert is the right leader at the right time for Titomic. The new leadership team, employees, partners, customers and shareholders will all benefit under Herbert’s leadership. On behalf of the Board, I thank Norbert for his outstanding contribution as Interim CEO and in particular his great support in defining the new strategic direction of the Company."
Herbert Koeck commented: “It is an honour to accept this position as CEO of Titomic. As a team, Titomic’s employees have contributed their skills and talents to position Titomic as a leading global additive manufacturing company. The opportunity is vast for Titomic, and to capture the potential we must focus clearly, move fast and continue to transform. I am very excited and passionate to lead this process."
Herbert Koeck as CEO adds to Titomic’s new executive management team consisting of Jeff Lang as CTO, Chris Healy as Chief Legal Officer and Joanna Walker as CFO. The transformation of the management team comes in addition to the recent changes to the Titomic Board of Directors which now includes Chairman Dr Andreas Schwer former CEO of SAMI, Mira Ricardel principal Chertoff Group and former White House official, business executive Humphrey Nolan, Dag W.R. Stromme former Morgan Stanley Managing Director and private equity executive, business executive Richard Willson, and co-founders of Titomic Prof Richard Fox and Jeff Lang.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210525006057/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network12.11.2026 18:00:00 CET | Press release
New feature lets members follow friends and family, share performance and health insights, and celebrate life's moments together WHOOP, the human performance brand, today launched WHOOP Humans, a new feature that lets members follow friends and family, share fitness, health, and performance data they choose, and support each other's progress. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112176779/en/ WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network For more than a decade, WHOOP has helped members better understand their own health and performance. Now, WHOOP Humans extends that experience beyond the individual, making it easier to celebrate achievements, encourage progress, and look out for the people who matter most. "In a world that's becoming increasingly artificial, we're building something deeply human,” said Will Ahmed, Founder and CEO of WHOOP. “This is the most verifiably human network ever
Integrated Hubs for Green Chemistry Research Aim to Transform How Chemicals and Materials Are Designed12.11.2026 17:00:00 CET | Press release
International network will investigate fundamental principles for creating safer, higher-performing chemicals and materials The Gordon and Betty Moore Foundation today announced four Integrated Research Hubs to explore new frontiers in chemical design, from materials that respond to their surroundings to molecules designed for safety from the start. Bringing together global researchers across institutions and disciplines, the hubs will investigate fundamental principles that could enable new capabilities in chemicals and materials while improving performance and protecting human health and the environment. The research priorities emerged through extensive engagement with the scientific community to identify the questions that could transform what chemistry can achieve. Each hub will connect researchers across institutions around one of four green chemistry focus areas: Safer molecular design: Led by The George Washington University, this hub will combine artificial intelligence and qua
Roquette Highlights Scalable Excipient and Capsule Solutions for Regional and Global Pharmaceutical Markets at CPHI India 202612.11.2026 16:00:00 CET | Press release
Helping pharmaceutical manufacturers accelerate the journey from formulation to market through deep technical expertise, meaningful innovation, close collaboration and global capabilities Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical excipients, will showcase its comprehensive portfolio of excipient and capsule solutions at CPHI India 2026, Hall 1, Booth 1I12 from November 23 to 25, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112803410/en/ Meet Roquette at CPHI India 2026, Hall 1, Booth 1I12 At the event, Roquette will demonstrate how it helps pharmaceutical manufacturers accelerate the journey from formulation to market with confidence. By combining technical expertise, trusted quality, meaningful innovation and close collaboration, Roquette helps customers address formulation, scale-up and manufacturing challenges across a broad range of pharmaceutical application
Tigo Energy and Google Cloud Pair AI-Powered Tools for Solar Installers and Utilities12.11.2026 15:00:00 CET | Press release
The collaboration combines Tigo software with Google’s Gemini models on Google Cloud to help automate installer and utility operations for distributed energy portfolios. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy software solutions, today announced a collaboration with Google Cloud to develop AI-enabled operational workflows for solar installers and distributed energy portfolios. By making core Tigo data and software products available through Google Cloud, Tigo aims to deliver faster deployment, simplified data integration, and additional insights with Gemini. The resulting workflows will help installers, asset managers, and energy operators more easily identify issues, prioritize actions, and automate routine operational tasks across growing fleets of distributed energy systems. As solar and storage portfolios expand, energy businesses are increasingly responsible for managing more sites, more system data, and more custo
Patsnap Releases State of Pharma Intelligence 2026 Report, Reveals Pharma's Cautious Embrace of AI in Decision-Making12.11.2026 15:00:00 CET | Press release
A new survey of 130 senior life sciences leaders on AI in pharma R&D and competitive intelligence finds that 92% can name a recent R&D, portfolio, or partnership decision where AI changed the outcome. Patsnap, the AI-native innovation intelligence company for IP and R&D teams, today released "State of Pharma Intelligence 2026: The Confidence to Act", a benchmark report on how pharma teams use and trust AI in R&D, competitive intelligence and business development decisions. The report draws on responses from 130 senior leaders at Director level or above across the United States, the United Kingdom, Germany, Switzerland, and France, spanning drug developers, CDMOs/CMOs, CROs, and consulting and professional services firms. The survey was fielded in August 2026 in partnership with NewtonX. Patsnap commissioned the research to understand how AI is influencing decisions across pharma R&D and business development, what builds confidence in its output, and where intelligence workflows fall sh
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom